Skip to main content
. 2021 May 21;49(W1):W304–W316. doi: 10.1093/nar/gkab359

Figure 4.

Figure 4.

Performance of the final selected KEA3 libraries and integration methods in recovering the perturbed and drug-targeted kinase(s) from the three benchmarking datasets. (AC) ROC curves for KinCREEDSupdn, DrugL1000updn, and PTMsigDB.drug, respectively; (DF) Composite PR curves generated from 5,000 bootstrapped curves for KinCREEDSupdn, DrugL1000updn, and PTMsigDB.drug, respectively; (GI) The deviation of the cumulative distribution from uniform of the scaled rankings of the ‘true’ kinases for KinCREEDSupdn, DrugL1000updn and PTMsigDB.drug, respectively.